Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review

References

• Depression. Fact sheet 369[webpage on the Internet]GenevaWorld Health Organization2012 Available from: http://www.who.int/mediacentre/factsheets/fs369/en/Accessed January 14, 2014
   Google Scholar
• FrazerABenmansourSDelayed pharmacological effects of antidepressantsMol Psychiatry20027Suppl 1S23S2811986992
   PubMed Web of Science ®Google Scholar
• Al-HarbiKSTreatment-resistant depression: therapeutic trends, challenges, and future directionsPatient Prefer Adherence2012636938822654508
   PubMed Web of Science ®Google Scholar
• BermanRMCappielloAAnandAAntidepressant effects of ketamine in depressed patientsBiol Psychiatry200047435135410686270
   PubMed Web of Science ®Google Scholar
• DiazGranadosNIbrahimLABrutscheNERapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorderJ Clin Psychiatry201071121605161120673547
   PubMed Web of Science ®Google Scholar
• MurroughJWIosifescuDVChangLCAntidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trialAm J Psychiatry2013170101134114223982301
   PubMed Web of Science ®Google Scholar
• SosPKlirovaMNovakTKohutovaBHoracekJPalenicekTRelationship of ketamine’s antidepressant and psychotomimetic effects in unipolar depressionNeuro Endocrinol Lett201334428729323803871
   PubMed Web of Science ®Google Scholar
• ValentineGWMasonGFGomezRThe antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRSPsychiatry Res2011191212212721232924
   PubMed Web of Science ®Google Scholar
• ZarateCAJrSinghJBCarlsonPJA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depressionArch Gen Psychiatry200663885686416894061
   PubMed Web of Science ®Google Scholar
• ZarateCAJrBrutscheNEIbrahimLReplication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trialBiol Psychiatry2012711193994622297150
   PubMed Web of Science ®Google Scholar
• LallyNNugentACLuckenbaughDAAmeliRRosierJPZarateCAAnti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depressionTransl Psychiatry20144e46925313512
   PubMed Web of Science ®Google Scholar
• MurroughJWPerezAMPillemerSRapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depressionBiol Psychiatry201374425025622840761
   PubMed Web of Science ®Google Scholar
• aan het RotMCollinsKAMurroughJWSafety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depressionBiol Psychiatry201067213914519897179
   PubMed Web of Science ®Google Scholar
• FondGLoundouARabuCKetamine administration in depressive disorders: a systematic review and meta-analysisPsychopharmacology (Berl)2014231183663367625038867
   PubMed Web of Science ®Google Scholar
• McGirrABerlimMTBondDJFleckMPYathamLNLamRWA systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodesPsychol Med201545469370425010396
   PubMed Web of Science ®Google Scholar
• LuckenbaughDANiciuMJIonescuDFDo the dissociative side effects of ketamine mediate its antidepressant effects?J Affect Disord2014159566124679390
   PubMed Web of Science ®Google Scholar
• IrwinSAIglewiczANelesenRADaily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trialJ Palliat Med201316895896523805864
   PubMed Web of Science ®Google Scholar
• IglewiczAMorrisonKNelesenKAKetamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one casesPsychosomatics201556432933725616995
   PubMed Web of Science ®Google Scholar
• IrwinSAIglewiczAOral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice careJ Palliat Med201013790390820636166
   PubMed Web of Science ®Google Scholar
• ChilukuriHReddyMPPathapatiRMManuANJolluSShaikABAcute antidepressant effects of intramuscular versus intravenous ketamineIndian J Psychol Med2014361717624701015
   PubMedGoogle Scholar
• CusinCHiltonGQNierenbergAAFavaMLong-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depressionAm J Psychiatry2012169886886922854933
   PubMed Web of Science ®Google Scholar
• LapidusKALevitchCFPerezAMA randomized controlled trial of intranasal ketamine in major depressive disorderBiol Psychiatry2014761297097624821196
   PubMed Web of Science ®Google Scholar
• LaraDRBisolLWMunariLRAntidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depressionInt J Neuropsychopharmacol20131692111211723683309
   PubMed Web of Science ®Google Scholar
• PaslakisGGillesMMeyer-LindenbergADeuschleMOral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case seriesPharmacopsychiatry2010431333520013614
   PubMed Web of Science ®Google Scholar
• GluePGulatiALe NedelecMDuffullSDose- and exposure-response to ketamine in depressionBiol Psychiatry2011704e9e10 author reply e11–e1221481846
   PubMed Web of Science ®Google Scholar
• ZanicottiCGPerezDGluePMood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancerJ Palliat Med201215440040322468772
   PubMed Web of Science ®Google Scholar
• McNultyJPHahnKCompounded oral ketamineInt J Pharm Compd201216536436823072195
   PubMedGoogle Scholar
• DiBonaventuraMDWagnerJSGirmanCJMultinational Internet-based survey of patient preference for newer oral or injectable type 2 diabetes medicationPatient Prefer Adherence2010439740621206515
   PubMed Web of Science ®Google Scholar
• YawnBPColiceGLHodderRPractical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care settingInt J Chron Obstruct Pulmon Dis2012749550222888221
   PubMed Web of Science ®Google Scholar
• YanagiharaYOhtaniMKariyaSPlasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteersBiopharm Drug Dispos2003241374312516077
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnosis and Statistical Manual of Mental DisordersFourth Edition Text RevisionWashingtonAmerican Psychiatric Association2000
   Google Scholar
• CampbellRJCampbell’s Psychiatric Dictionary9th edNew YorkOxford University Press2009
   Google Scholar